Stem cell therapy restores transparency to defective murine corneas

Area of Science:

• Ophthalmology
• Regenerative Medicine
• Stem Cell Biology

Background:

• Corneal scarring from trauma and inflammation causes vision loss globally.
• Corneal transplantation is limited by availability, leaving many without treatment for corneal blindness.

Purpose of the Study:

• To investigate the potential of adult human corneal stromal stem cells for treating corneal opacity.
• To evaluate the efficacy and safety of direct stem cell injection into the corneal stroma in a murine model.

Main Methods:

• Isolation and injection of adult human corneal stromal stem cells into wild-type and lumican-null mice.
• Assessment of stem cell viability, host immune response, extracellular matrix accumulation, and corneal structure/transparency.

Main Results:

• Injected human stem cells survived long-term without immune rejection or fusion with host cells.
• Treated corneas showed accumulation of human corneal extracellular matrix, including lumican and keratocan.
• Stem cell therapy restored stromal thickness and collagen organization in lumican-null mice, leading to restored corneal transparency.

Conclusions:

• Adult human corneal stem cells are immune-privileged and can regenerate corneal tissue.
• Stem cell therapy offers a novel approach to treating corneal opacity and blindness, distinct from conventional wound healing.
• This cell-based therapy holds potential for treating human corneal blindness.